- Home
- GROY vs KOD Comparison
GROY vs KOD Comparison
Compare GROY & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GROY | KOD |
|---|---|---|
| Founded | 2020 | 2009 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 938.2M | 795.5M |
| IPO Year | 2021 | 2018 |
Fundamental Metrics
Financial Performance| Metric | GROY | KOD |
|---|---|---|
| Price | $4.20 | $29.93 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $5.00 | ★ $22.67 |
| AVG Volume (30 Days) | ★ 3.4M | 929.1K |
| Earning Date | 11-05-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $14,464,000.00 | N/A |
| Revenue This Year | $72.11 | N/A |
| Revenue Next Year | $100.63 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 86.30 | N/A |
| 52 Week Low | $1.16 | $1.92 |
| 52 Week High | $4.49 | $31.18 |
Technical Indicators
Market Signals| Indicator | GROY | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 58.10 | 67.09 |
| Support Level | $4.08 | $25.44 |
| Resistance Level | $4.23 | $31.18 |
| Average True Range (ATR) | 0.18 | 2.23 |
| MACD | -0.00 | 0.38 |
| Stochastic Oscillator | 88.44 | 86.73 |
Price Performance
Historical ComparisonAbout GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.